These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11679979)

  • 21. Role of hepatic stellate cells in the pathogenesis of portal hypertension.
    Marra F; Pinzani M
    Nefrologia; 2002; 22 Suppl 5():34-40. PubMed ID: 12107915
    [No Abstract]   [Full Text] [Related]  

  • 22. Up-regulation of nNOS and associated increase in nitrergic vasodilation in superior mesenteric arteries in pre-hepatic portal hypertension.
    Jurzik L; Froh M; Straub RH; Schölmerich J; Wiest R
    J Hepatol; 2005 Aug; 43(2):258-65. PubMed ID: 15963596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation.
    Arkenau HT; Stichtenoth DO; Frölich JC; Manns MP; Böker KH
    Z Gastroenterol; 2002 Nov; 40(11):907-13. PubMed ID: 12436367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nitric oxide in pathogenesis of cirrhotic portal hypertension in rats and its hemodynamic effects].
    Zhang J; Zhou H
    Zhonghua Wai Ke Za Zhi; 1998 May; 36(5):317-9. PubMed ID: 11825400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension.
    Coll M; Genescà J; Raurell I; Rodríguez-Vilarrupla A; Mejías M; Otero T; Oria M; Esteban R; Guardia J; Bosch J; Martell M
    J Hepatol; 2008 Jul; 49(1):43-51. PubMed ID: 18457899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitric oxide and hyperdynamic circulation in portal hypertension.
    Häussinger D
    Hepatology; 1992 Oct; 16(4):1093-4. PubMed ID: 1398491
    [No Abstract]   [Full Text] [Related]  

  • 27. [Role of vascular nitric oxide in experimental liver cirrhosis].
    Atucha NM; Nadal FJ; Iyu D; García-Estañ J
    Nefrologia; 2002; 22 Suppl 5():25-8. PubMed ID: 12107913
    [No Abstract]   [Full Text] [Related]  

  • 28. Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis.
    Yang YY; Huang YT; Lee KC; Lee FY; Lee TY; Hou MC; Lin HC; Lee SD
    Clin Sci (Lond); 2009 Jan; 116(1):71-9. PubMed ID: 18479249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Splanchnic and systemic vasodilatation: the patient.
    Tsai MH
    J Clin Gastroenterol; 2007; 41 Suppl 3():S266-71. PubMed ID: 17975476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of vasoactive mediators in portal hypertension.
    García-Pagán JC; Bosch J; Rodés J
    Semin Gastrointest Dis; 1995 Jul; 6(3):140-7. PubMed ID: 7551971
    [No Abstract]   [Full Text] [Related]  

  • 31. Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.
    Gatta A; Bolognesi M; Merkel C
    Mol Aspects Med; 2008; 29(1-2):119-29. PubMed ID: 18036654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state.
    Abraldes JG; Iwakiri Y; Loureiro-Silva M; Haq O; Sessa WC; Groszmann RJ
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G980-7. PubMed ID: 16603731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The future treatment of portal hypertension.
    Reichen J; Lebrec D
    Best Pract Res Clin Gastroenterol; 2007; 21(1):191-202. PubMed ID: 17223505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
    Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nitric oxide and hyperdynamic circulation in liver cirrhosis].
    Wang Y; Gu C
    Zhonghua Nei Ke Za Zhi; 1995 Nov; 34(11):779-81. PubMed ID: 8731852
    [No Abstract]   [Full Text] [Related]  

  • 36. Hemodynamics in the isolated cirrhotic liver.
    Zipprich A
    J Clin Gastroenterol; 2007; 41 Suppl 3():S254-8. PubMed ID: 17975473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term portal hypertension increases the vasodilator response to acetylcholine in rat aorta: role of prostaglandin I2.
    Blanco-Rivero J; Aller MA; Arias J; Ferrer M; Balfagón G
    Clin Sci (Lond); 2009 Sep; 117(10):365-74. PubMed ID: 19331646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hyperdynamic circulatory syndrome of chronic liver disease: physiopathology of a multiorganic entity].
    López-Talavera JC; Groszmann RJ
    Med Clin (Barc); 1995 Jun; 105(1):13-5. PubMed ID: 7637409
    [No Abstract]   [Full Text] [Related]  

  • 39. Portal hypertension in early-stage primary biliary cirrhosis: a possible explanation.
    Arora S; Kaplan M
    Am J Gastroenterol; 1987 Jan; 82(1):90-1. PubMed ID: 3799588
    [No Abstract]   [Full Text] [Related]  

  • 40. Pathogenesis of portal hypertension.
    Lebrec D; Moreau R
    Eur J Gastroenterol Hepatol; 2001 Apr; 13(4):309-11. PubMed ID: 11338055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.